VB1-050 (Sesen Bio)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVB1-050 (Sesen Bio)
Drug Alias NameVB1-050VBX-050
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionEpithelial cell adhesion molecule modulatorsRibosomal protein S6 kinase inhibitorsGlucose transporter 1 inhibitors +[4] 
TargetsRibosomal protein S6 kinaseCD44 antigenGlucose transporter 1 +[4] 
Therapy Area/IndicationsProstatic NeoplasmsLiver NeoplasmsStomach Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSesen Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSesen Bio Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsLiver NeoplasmsStomach Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A